Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert W Leong

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
Alimentary Pharmacology & Therapeutics|October 10, 2024
Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel DiseasesRupert W Leong, Anthony Sakiris, Arteen Arzivian, et al.
Intestinal Research|December 2, 2024
Knowledge and perspectives towards the use of histology in inflammatory bowel disease by gastroenterologists across the Asia-Pacific regionThanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, et al.
Therapeutic Advances in Gastroenterology|September 13, 2023
IBD barriers across the continents: a continent-specific analysis - AustralasiaAlexander T Elford, Rupert W Leong, Emma P Halmos, et al.
Nature Communications|October 17, 2024
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remissionMarwan E Majzoub, Sudarshan Paramsothy, Craig Haifer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 23, 2013
A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapyGeoffrey M Forbes, Marian J Sturm, Rupert W Leong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2013
Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel diseaseChristian P Selinger, Jane M Andrews, Andrew Titman, et al.
Msystems|August 13, 2024
Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profilingMarwan E Majzoub, Laurence D W Luu, Craig Haifer, et al.
Msystems|September 15, 2025
Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitisShreeya S Raich, Marwan E Majzoub, Craig Haifer, et al.
Inflammatory Bowel Diseases|June 15, 2013
Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitisChristian P Selinger, Jane Andrews, Owen F Dent, et al.
Journal of Medical Microbiology|February 7, 2015
Investigation of the effects of pH and bile on the growth of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease and controlsRena Ma, Nicholas Sapwell, Heung Kit Leslie Chung, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Alimentary Pharmacology & Therapeutics|October 10, 2024
Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel DiseasesRupert W Leong, Anthony Sakiris, Arteen Arzivian, et al.
Intestinal Research|December 2, 2024
Knowledge and perspectives towards the use of histology in inflammatory bowel disease by gastroenterologists across the Asia-Pacific regionThanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, et al.
Therapeutic Advances in Gastroenterology|September 13, 2023
IBD barriers across the continents: a continent-specific analysis - AustralasiaAlexander T Elford, Rupert W Leong, Emma P Halmos, et al.
Nature Communications|October 17, 2024
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remissionMarwan E Majzoub, Sudarshan Paramsothy, Craig Haifer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 23, 2013
A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapyGeoffrey M Forbes, Marian J Sturm, Rupert W Leong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2013
Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel diseaseChristian P Selinger, Jane M Andrews, Andrew Titman, et al.
Msystems|August 13, 2024
Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profilingMarwan E Majzoub, Laurence D W Luu, Craig Haifer, et al.
Msystems|September 15, 2025
Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitisShreeya S Raich, Marwan E Majzoub, Craig Haifer, et al.
Inflammatory Bowel Diseases|June 15, 2013
Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitisChristian P Selinger, Jane Andrews, Owen F Dent, et al.
Journal of Medical Microbiology|February 7, 2015
Investigation of the effects of pH and bile on the growth of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease and controlsRena Ma, Nicholas Sapwell, Heung Kit Leslie Chung, et al.
Pageof 16